Follow us on LinkedIn - https://www.linkedin.com/company/fatty-liver-alliance/
Follow us on LinkedIn - https://www.linkedin.com/company/fatty-liver-alliance/
The Canadian Obesity Advocacy Network (COAN) is a diverse network of forward-thinking NGOs, companies, foundations, agencies, academics, clinicians and groups of people living with obesity that have come together with the purpose of changing the narrative of obesity in Canada. The COAN sits under the umbrella of Obesity Canada and is committed to collectively addressing bias and stigma, education, access to care and advocacy in Canada.
AwareNASH is a research project with the objective to educate clinicians managing patients with NAFLD and NASH on the importance of prompt diagnosis (especially in the case of NASH), along with the relationship of NAFLD/NASH to metabolic disease and CVD. It is funded by an independent educational grant provided by Pfizer.
Metabolism and Target Organ Damage (M&TOD, https://mtodjournal.net ) is an international, peer-reviewed, open-access interdisciplinary journal that provides an online platform for the publication of clinical, basic, and translational studies. It covers (cardio)-metabolic disorders per se, such as obesity, diabetes, dyslipidemias, arterial hypertension, and hyperuricemia in all age groups. Of note, this journal will emphasize the role of these metabolic disorders as either effectors/amplifiers or consequences of the development and progression of injuries to target organs including but not limited to the cardiovascular system, the liver, kidneys, and the pancreas. Specific applications in metabolic disorders are as follows: history of the disease, epidemiology, prevention, natural history, genetics, cell, and molecular biology, pathobiochemistry, physiopathology, anatomic pathology, clinical chemistry, pharmaceutical chemistry, pharmacology, psychology, psychiatry, statistics, and immunology.
Our NAFLD Studies: https://mtodjournal.net/search/search?clearPageContext=1&searchJournal=26&searchVal=fatty+liver
We’re committed to improving the lives of people with gastrointestinal and liver conditions, supporting research, advocating for appropriate patient access to healthcare, and promoting gastrointestinal and liver health.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.